Salla Keskitalo Selected Research

Salla Keskitalo Research Topics

Disease

7	Neoplasms (Cancer) 08/2023 - 06/2008
4	Inflammation (Inflammations) 12/2021 - 01/2013
2	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2021 - 03/2005
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2018
2	Leiomyoma (Uterine Fibroids) 01/2016 - 05/2014
2	Multiple Sclerosis 03/2014 - 06/2013
2	Hyperhomocysteinemia 01/2013 - 03/2011
1	Necrotizing Fasciitis 04/2024
1	Alzheimer Disease (Alzheimer's Disease) 07/2023
1	Neuroinflammatory Diseases 07/2023
1	Common Variable Immunodeficiency 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Myoma 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Liver Diseases (Liver Disease) 12/2021
1	Papilloma (Papillomatosis) 12/2021
1	Anemia 12/2021
1	Thyroid Diseases (Thyroid Disease) 12/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 12/2021
1	Bites and Stings (Sting) 01/2019
1	Ulcer 01/2019
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017
1	Phyllodes Tumor (Cystosarcoma Phylloides) 01/2016
1	Fibroadenoma 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Disease Progression 03/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2013
1	Hemangioma (Angioma) 01/2013
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2011
1	Ischemia 05/2007
1	Cysts 03/2005
1	Alopecia (Baldness) 03/2005

Drug/Important Bio-Agent (IBA)

4	Phosphotransferases (Kinase)IBA 07/2023 - 06/2008
4	Proteins (Proteins, Gene)FDA Link 07/2023 - 04/2013
3	HomocysteineIBA 03/2014 - 03/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 05/2007
2	InflammasomesIBA 04/2024 - 01/2019
2	veltuzumabIBA 12/2021 - 01/2018
2	RNA Polymerase II (RNA Polymerase B)IBA 01/2016 - 05/2014
2	Cyclin CIBA 01/2016 - 05/2014
1	Interferon Type IIBA 04/2024
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2023
1	ApolipoproteinsIBA 07/2023
1	Amyloid (Amyloid Fibrils)IBA 07/2023
1	Complement System Proteins (Complement)IBA 07/2023
1	Apolipoproteins E (ApoE)IBA 07/2023
1	Apolipoprotein E4IBA 07/2023
1	Helix lectinIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	Polysaccharides (Glycans)IBA 01/2022
1	IntegrinsIBA 01/2022
1	LectinsIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Messenger RNA (mRNA)IBA 08/2021
1	Formaldehyde (Formol)FDA Link 01/2019
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2019
1	anagrelide (Agrylin)FDA LinkGeneric 01/2019
1	Janus Kinase 1IBA 01/2019
1	InterferonsIBA 01/2019
1	Nucleic AcidsIBA 01/2019
1	baricitinibIBA 01/2019
1	Nonsense Codon (Nonsense Mutation)IBA 01/2017
1	Leucine (L-Leucine)FDA Link 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2016
1	Methionine (L-Methionine)FDA Link 03/2014
1	Prolyl OligopeptidasesIBA 06/2013
1	ProteomeIBA 04/2013
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2013
1	5-methyltetrahydrofolateIBA 01/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2013
1	Oxidoreductases (Dehydrogenase)IBA 03/2011
1	5,10-methylenetetrahydrofolic acidIBA 03/2011
1	CopperIBA 03/2011
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 06/2008
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2008
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 06/2008
1	Tyrosine Kinase InhibitorsIBA 06/2008
1	cediranib (AZD2171)IBA 06/2008
1	Vascular Endothelial Growth Factor CIBA 06/2008
1	SpermineIBA 03/2005
1	SpermidineIBA 03/2005
1	PutrescineIBA 03/2005
1	PolyaminesIBA 03/2005
1	EnzymesIBA 03/2005

Therapy/Procedure

3	Therapeutics 08/2023 - 05/2007